Consistent amplification of JAK2 in hematological malignancies with hsr(9)(p).
Iwona Włodarska(KU Leuven), Peter Marynen(Vlaams Instituut voor Biotechnologie), Jan Cools(KU Leuven), Ruth Achten(Jessa Hospital), Anne Hagemeijer(Radboud University Nijmegen), Sabine Franke(KU Leuven), G. Verhoef, Lucienne Michaux(Vlaams Instituut voor Biotechnologie), C. De Wolf‐Peeters(KU Leuven), Patrick Peeters
DIAL (Catholic University of Leuven)
January 1, 2000
Cited by 0
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
|Gastroenterology|2005|494
Oxidative Stress and Oval Cell Accumulation in Mice and Humans with Alcoholic and Nonalcoholic Fatty Liver Disease
|American Journal Of Pathology|2003|448
Submicroscopic Duplications of the Hydroxysteroid Dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 Are Associated with Mental Retardation
|The American Journal of Human Genetics|2008|223